Senior Director - Acquisitions Integration Lead. at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, HealthcareIndustries

Requirements

Bachelor's degree required. MS, MBA, PhD, PharmD preferred
10+ years of experience in the biopharmaceutical industry with drug discovery and development processes and/or related areas

Responsibilities

Participate in technical and corporate due diligence and the transaction deal team processes to inform integration strategy and planning
Develop acquisition integration strategies including operating model and people strategy, define integration priorities based on risks from diligence and business objectives, and gain alignment with Sr. Leadership
Create acquisition transition roadmap to drive alignment and optimize transparency among leaders and target company employees during integration planning & execution
Develop comprehensive integration plans, including timelines & resource allocation (in partnership with HR)
Lead integration meetings and coordinate activities and dependencies across functions – ensuring functions remain properly informed of priorities
Track and report integration progress aligned with the established KPIs
Identify TA Business Lead, Program Management Lead (COO) and other key functional leads to support the integration
Establish governance and responsibilities related to decision-making
Resolve major issues and proactively manage risks, while rapidly escalating any issues that cannot be quickly resolved
Build and maintain contacts with key stakeholders and decision makers in the TA and functional areas
Drive continuous improvement to strengthen the ATT brand and increase efficiency and consistency across acquisitions
Seek to understand and represent the needs of the acquired companies. Timely and effectively communicate to and influence relevant stakeholders and decision makers
Coach and develop team members and others within and outside the organization to effectively develop talent and establish succession plan for key roles
Foster a collaborative, positive and inclusive work environment

Skills

M&A Integration

Due Diligence

Integration Strategy

Stakeholder Management

Cross-Functional Leadership

Business Development

Alliance Management

Process Improvement

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free